Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: A double-blind, randomised, three-attack study

European Neurology

Volumn 47, Issue 2, 2002, Pages 88-98

  Geraud, G ^a   Compagnon, A ^a   Rossi, A ^a  

^a CHU RANGUEIL   (France)

Author keywords

Acetylsalicylic acid; Clinical trial; Metoclopramide; Migraine; Zolmitriptan

Indexed keywords

ACETYLSALICYLIC ACID; METOCLOPRAMIDE; ZOLMITRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA AND VOMITING; PATIENT SATISFACTION; PHLEBITIS; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ASPIRIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METOCLOPRAMIDE; MIDDLE AGED; MIGRAINE DISORDERS; OXAZOLIDINONES; SEROTONIN AGONISTS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 0036178936     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047959     Document Type: Article

References (35)

1. Measuring the functional status and well-being of patients with migraine headache
2. The economic and social impact of migraine
3. Loss of productivity and quality of life in migraine sufferers among French workers: Results from the GAZEL cohort
4. Burden of migraine: Societal costs and therapeutic opportunities
5. Evolution of the measurement of quality of life in migraine
6. A nationwide survey of migraine in France: Prevalence and clinical features in adults. GRIM
7. Prevalence of migraine headache in the United States
8. Migraine prevalence. A review of population based studies
9. Epidemiology of headache
10. Prevalence and sex ratio of the subtypes of migraine
11. Analgesics and NSAIDs in the treatment of the acute migraine attack
12. Use of over-the-counter drugs in migraine - Issues in self-medication
13. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: A multicentre double-blind placebo-controlled study
14. Current concepts of migraine pathogenesis
15. 1 receptors in migraine pathophysiology and treatment
16. 1B/1D agonist for migraine
17. 1B/1D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic targets in migraine?
18. Direct evidence for central sites of action of zolmitriptan (311C90): An autoradiography study in cat
19. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study
20. 1B/1D receptor agonists
21. Efficacy of zolmitriptan at early time-points for the acute treatment of migraine and treatment of recurrence
22. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
23. A triptan too far?
24. Migraine
25. Methodology of treatment trials for acute migraine attacks
26. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine
27. A randomised, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine
28. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine
29. Stratified care vs step care strategies for migraine: The Disability in Strategies of Care (DISC) Study: A randomized trial
30. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with sumatriptan for migraine
31. Evaluation of the long-term safety and efficacy of zolmitriptan (311C90) in the treatment of migraine
32. 1B/1D agonist: An overview of efficacy
33. Zolmitriptan provides consistent migraine relief when used in the long-term
34. 1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan
35. The safety profile of sumatriptan